Skip to content
Company Analysis

NeuroMetrix, Inc. NURO

A comprehensive view of key metrics, scores, and financial health for NeuroMetrix, Inc.

Overview of NeuroMetrix, Inc.

NURO NGM
Healthcare Medical Devices
NeuroMetrix, Inc. (NURO), in the Medical Devices industry.
-
-
As of Feb. 10, 2026
Previous close
Enterprise Value
-
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Weak
Health
Fair
Efficiency
Fair
Growth
Weak
Profitability
Weak
Health
Fair
Efficiency
Fair
Completeness: 62%
Confidence: 69%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

Website https://www.neurometrix.com
HQ Woburn, MA
Employees 13
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Insufficient data
Show more details
  • Shares outstanding missing or non-positive

Engine Room Money Flow™

Corporate Free Cash Flow - Where revenue goes and how value is created

Flow Steps
Revenue
$3.0M
-48.6%%
Gross Profit
$1.7M
-57.4%%
Operating Income
$-8.8M
-22.8%%
Net Income
$-7.8M
-19.6%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Corporate Free Cash Flow

Quality & Reliability Indicators

Operating Cash Flow Margin
-235.0%
Poor

OCF / Revenue - cash profitability from operations

Where It Leaks

Cash Flow Health healthy
Strong cash conversion with minimal leakage across profit-to-cash-to-value chain.
Analysis based on partial data. Some metrics unavailable for complete assessment.
0
Active Leaks
0/0
Improving
0
High Impact
0
Critical
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating NeuroMetrix, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
34
/100
Developing
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Developing
30
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 64% Coverage
Trade-Off Triangle Visualization A ternary plot showing NURO's balance between Growth (6.0%), Profitability (30.5%), and Safety (63.4%). Growth 6% Safety 63% Profitability 31%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

5th percentile vs peers
6
Key Signals
Rev Growth YoY -48.6% 6p Revenue CAGR 3Y -28.4% 5p
Strengths
  • Current Ratio in top 20% of peers (14.83, 98th percentile)
  • Quick Ratio in top 20% of peers (13.50, 98th percentile)
  • Strong liquidity position vs peers
Risks
  • Growth in bottom 20% of peers (percentile: 5)
  • Rev Growth YoY in bottom 20% of peers (-48.6%)

Profitability

29th percentile vs peers
30
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

61th percentile vs peers
61
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for NeuroMetrix, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
-
- - -
- upside
-
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info